Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least squares (OLS)...
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
Clearance Models: Noncompartmental Models01:17

Clearance Models: Noncompartmental Models

Clearance is a pharmacokinetic parameter traditionally defined by compartment models, signifying the rate at which a drug is expelled from the body. However, a noncompartmental model offers an alternative method for assessing clearance, primarily employing empirical data obtained after administering a single drug dose.
The noncompartmental approach capitalizes on extensive sampling data, correlating the volume of distribution to systemic exposure and the administered dosage. This method enables...
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Multicompartment Models: Overview01:14

Multicompartment Models: Overview

Multicompartment models are mathematical constructs that depict how drugs are distributed and eliminated within the body. They segment the body into several compartments, symbolizing various physiological or anatomical areas connected through drug transfer processes such as absorption, metabolism, distribution, and elimination.
These models offer a more comprehensive representation of drug behavior in the body than one-compartment models. They accommodate the complexity of drug distribution,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nonparametric inference for the localization receiver operating characteristic curve and its extension to free-response image localization tasks.

Statistical methods in medical research·2026
Same author

Predicting transitions in alcohol use among adolescents and young adults by nicotine and tobacco products used.

Drug and alcohol dependence·2026
Same author

Disparities in mental health help-seeking and treatment utilization by race, ethnicity, and severity of mental health symptoms among college students.

Journal of American college health : J of ACH·2026
Same author

Copas-Heckman-Type Sensitivity Analysis for Publication Bias in Rare-Event Meta-Analysis Under Generalized Linear Mixed Models.

Statistics in medicine·2026
Same author

miRNAs-neutrophil axis: novel insights into acute lung injury and chronic inflammatory lung diseases.

Frontiers in immunology·2026
Same author

Traditional Chinese Medicine in Cushing's Syndrome: A Narrative Review of Pathophysiology and Potential Therapeutic Effects.

OncoTargets and therapy·2026

Related Experiment Video

Updated: May 10, 2026

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach
04:35

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach

Published on: July 3, 2020

A Correlated Random Effects Model for Non-homogeneous Markov Processes with Nonignorable Missingness.

Baojiang Chen1, Xiao-Hua Zhou

  • 1Department of Biostatistics, University of Nebraska Medical Center, Omaha, NE 68198 USA.

Journal of Multivariate Analysis
|July 6, 2013
PubMed
Summary

This study introduces a new statistical method for analyzing incomplete patient health data over time. The approach effectively models disease progression using non-homogeneous Markov processes, improving accuracy in complex life history data analysis.

Keywords:
ClusterMarkov non-homogeneousmissing not at randomrandom effectstransition intensity

Related Experiment Videos

Last Updated: May 10, 2026

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach
04:35

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach

Published on: July 3, 2020

Area of Science:

  • Biostatistics
  • Epidemiology
  • Longitudinal Data Analysis

Background:

  • Patient life history data often has missing information due to variable clinic visit schedules.
  • Markov process models are valuable for understanding disease progression but typically assume time homogeneity.
  • Existing methods struggle with non-homogeneous processes and incomplete clustered data.

Purpose of the Study:

  • To develop statistical methods for analyzing non-homogeneous Markov processes with incomplete clustered life history data.
  • To address non-ignorable missingness and time-dependent transition probabilities in patient data.
  • To provide a robust framework for modeling complex disease progression patterns.

Main Methods:

  • Developed a correlated random effects model to handle non-ignorable missing data.
  • Employed a time transformation technique to account for non-homogeneity in transition models.
  • Utilized Maximum Likelihood Estimation via the Monte-Carlo Expectation-Maximization (EM) algorithm for parameter estimation.

Main Results:

  • Simulation studies confirmed the proposed method's effectiveness across various scenarios.
  • The developed model accurately estimates parameters in non-homogeneous Markov processes with incomplete data.
  • The method demonstrated successful application in an Alzheimer's disease progression study.

Conclusions:

  • The proposed correlated random effects model with time transformation offers a powerful solution for analyzing incomplete, non-homogeneous Markov process data.
  • This methodology enhances the understanding of disease progression in complex patient populations.
  • The approach is particularly relevant for longitudinal health studies with missing data, such as Alzheimer's research.